table of content
1 Study Coverage
1.1 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction
1.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Outlook 2017 VS 2022 VS 2028
1.2.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales in US$ Million for the Year 2017-2028
1.2.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales in Volume for the Year 2017-2028
1.3 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Outlook 2017 VS 2022 VS 2028
1.3.1 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales in US$ Million for the Year 2017-2028
1.3.2 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales in Volume for the Year 2017-2028
1.4 NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States NASH (Non-alcoholic Steatohepatitis) Biomarkers in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Dynamics
1.5.1 NASH (Non-alcoholic Steatohepatitis) Biomarkers Industry Trends
1.5.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Drivers
1.5.3 NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Challenges
1.5.4 NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Segment by Type
2.1.1 Serum Biomarkers
2.1.2 Hepatic Fibrosis Biomarkers
2.1.3 Apoptosis Biomarkers
2.1.4 Oxidative Stress Biomarkers
2.1.5 Others
2.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size by Type
2.2.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size by Type
2.3.1 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Segment by Application
3.1.1 Pharma & CRO Industry
3.1.2 Hospitals
3.1.3 Diagnostic Labs
3.1.4 Academic Research Institutes
3.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size by Application
3.2.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size by Application
3.3.1 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Competitor Landscape by Company
4.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size by Company
4.1.1 Top Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturers Ranked by Revenue (2021)
4.1.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Manufacturer (2017-2022)
4.1.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Manufacturer (2017-2022)
4.1.4 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Price by Manufacturer (2017-2022)
4.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Concentration Ratio (CR)
4.2.1 NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of NASH (Non-alcoholic Steatohepatitis) Biomarkers in 2021
4.2.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturing Base Distribution, Product Type
4.3.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Type
4.3.3 Date of International Manufacturers Enter into NASH (Non-alcoholic Steatohepatitis) Biomarkers Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size by Company
4.5.1 Top NASH (Non-alcoholic Steatohepatitis) Biomarkers Players in United States, Ranked by Revenue (2021)
4.5.2 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Players (2020, 2021 & 2022)
4.5.3 United States NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales by Players (2020, 2021 & 2022)
5 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size by Region
5.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size in Volume by Region (2017-2028)
5.2.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales in Volume by Region: 2017-2022
5.2.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales in Volume Forecast by Region (2023-2028)
5.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size in Value by Region (2017-2028)
5.3.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales in Value by Region: 2017-2022
5.3.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size YoY Growth 2017-2028
6.1.2 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size YoY Growth 2017-2028
6.3.2 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size YoY Growth 2017-2028
6.4.2 Latin America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 GENFIT SA
7.1.1 GENFIT SA Corporation Information
7.1.2 GENFIT SA Description and Business Overview
7.1.3 GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Revenue and Gross Margin (2017-2022)
7.1.4 GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Products Offered
7.1.5 GENFIT SA Recent Development
7.2 Gilead Sciences, Inc. (GILD)
7.2.1 Gilead Sciences, Inc. (GILD) Corporation Information
7.2.2 Gilead Sciences, Inc. (GILD) Description and Business Overview
7.2.3 Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Products Offered
7.2.5 Gilead Sciences, Inc. (GILD) Recent Development
7.3 AstraZeneca
7.3.1 AstraZeneca Corporation Information
7.3.2 AstraZeneca Description and Business Overview
7.3.3 AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Revenue and Gross Margin (2017-2022)
7.3.4 AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Products Offered
7.3.5 AstraZeneca Recent Development
7.4 Novartis AG
7.4.1 Novartis AG Corporation Information
7.4.2 Novartis AG Description and Business Overview
7.4.3 Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Products Offered
7.4.5 Novartis AG Recent Development
7.5 Bristol-Myers Squibb Company
7.5.1 Bristol-Myers Squibb Company Corporation Information
7.5.2 Bristol-Myers Squibb Company Description and Business Overview
7.5.3 Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Products Offered
7.5.5 Bristol-Myers Squibb Company Recent Development
7.6 Allergan Plc
7.6.1 Allergan Plc Corporation Information
7.6.2 Allergan Plc Description and Business Overview
7.6.3 Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Products Offered
7.6.5 Allergan Plc Recent Development
7.7 Novo Nordisk A/S
7.7.1 Novo Nordisk A/S Corporation Information
7.7.2 Novo Nordisk A/S Description and Business Overview
7.7.3 Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Products Offered
7.7.5 Novo Nordisk A/S Recent Development
7.8 Boehringer Ingelheim
7.8.1 Boehringer Ingelheim Corporation Information
7.8.2 Boehringer Ingelheim Description and Business Overview
7.8.3 Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Products Offered
7.8.5 Boehringer Ingelheim Recent Development
7.9 Pfizer Inc
7.9.1 Pfizer Inc Corporation Information
7.9.2 Pfizer Inc Description and Business Overview
7.9.3 Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Products Offered
7.9.5 Pfizer Inc Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 NASH (Non-alcoholic Steatohepatitis) Biomarkers Industry Chain Analysis
8.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Distributors
8.3 NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Mode & Process
8.4 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales and Marketing
8.4.1 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Channels
8.4.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Distributors
8.5 NASH (Non-alcoholic Steatohepatitis) Biomarkers Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
